The Use of Molecular Analyses in Voided Urine for the Assessment of Patients with Hematuria

A 3-Plex Methylation Assay Combined with the FGFR3 Mutation Assay Sensitively Detects Recurrent Bladder Cancer in Voided Urine

(2013) R. Kandimalla et al.   CLINICAL CANCER RESEARCH

A Multigene Urine Test for the Detection and Stratification of Bladder Cancer in Patients Presenting with Hematuria

(2012) Paul O'Sullivan et al.   JOURNAL OF UROLOGY

The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria

(2011) Funso Abogunrin et al.   CANCER

Immunocytology Is a Strong Predictor of Bladder Cancer Presence in Patients With Painless Hematuria: A Multicentre Study

(2011) Eugene K. Cha et al.   EUROPEAN UROLOGY

Feasibility study of screening for bladder cancer with urinary molecular markers (the BLU-P project)

(2010) M.J. Roobol et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection

(2009) Yair Lotan et al.   BJU INTERNATIONAL

The effect of age and gender on bladder cancer: a critical review of the literature

(2009) Shahrokh F. Shariat et al.   BJU INTERNATIONAL